(Q54411935)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Misato Kikuchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Junji Tanaka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Takeshi Kondo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Satoshi Hashino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Masaharu Kasai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Mitsutoshi Kurosawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hiroshi Iwasaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Masanobu Morioka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tsugumichi Kawamura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Takashi Fukuhara

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yasutaka Kakinoki

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hajime Kobayashi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Satoshi Noto

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Masahiro Asaka

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Masahiro Imamura

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

10 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

481-489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20830615%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12185-010-0670-1

13 February 2020

exact match

0 references

cites work

Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia

1 reference

12 December 2020

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

1 reference

12 December 2020

Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation

1 reference

12 December 2020

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

12 December 2020

Significance of minimal residual disease in lymphoid malignancies

1 reference

12 December 2020

Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia

1 reference

12 December 2020

Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia

1 reference

12 December 2020

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease

1 reference

12 December 2020

Minimal residual disease in acute lymphoblastic leukemia

1 reference

12 December 2020

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

1 reference

12 December 2020

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

1 reference

12 December 2020

Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia

1 reference

12 December 2020

Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia

1 reference

12 December 2020

Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.

1 reference

12 December 2020

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

12 December 2020

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993.

1 reference

12 December 2020

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

12 December 2020

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study

1 reference

12 December 2020

Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation

1 reference

12 December 2020

Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients

1 reference

12 December 2020

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

1 reference

12 December 2020

Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia

1 reference

12 December 2020